Skip to content

Osteopathic effects in patientes with heart disease

Effects of osteopathic manipulative treatment ( OMT )in functionality of patients with congestive heart failure: a randomized clinical trial .

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3st9f3
Enrollment
Unknown
Registered
2015-04-17
Start date
2015-04-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congestive heart failure, peripheral artery disease , tracking the autonomic nervous system in young and elderly.

Interventions

Experimental group (EG ): 30 cardiac patients will be treated by manipulative osteopathic treatment consisting of spinal manipulations , soft tissue , fascia and viscera for 2 months, 1 time per week.
Dietary supplement
Other
E02.190.599.280
E02.190.599

Sponsors

FCE - Faculdade de Ceilândia
Lead Sponsor
FCE - Faculdade de Ceilândia
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: For the experimental group : Congestive heart failure , cardiovascular disease, Chagas disease For the control group : not having cardiovascular disease and be over 18 years.

Exclusion criteria

Exclusion criteria: For the experimental group : New York Heart Association class I, hemodynamically decompensated patient , signs or symptoms of cardiovascular worsening in the last 3 months. For the control group : cardiovascular disease , hypertension, surgeries , fibromioalgia , dysautonomia.

Design outcomes

Primary

MeasureTime frame
improvement in physical function in cardiac by cardiopulmonary exercise test with at least 20 % of the increase from baseline in the experimental group .

Secondary

MeasureTime frame
Increased heart rate variability , verified by heart rate variability by at least 20 % of the initial value in the experimental group ; increased blood flow in the brachial artery verified by evaluating flow -mediated vasodilatation measured as a percentage , at least 20% of its initial value increased in the experimental group ; decrease of blood biochemical markers, the blood verified by examining at least 20 % decrease from baseline in experimental group ;

Countries

Brazil

Contacts

Public ContactFellipe Teixeira

Universidade de Brasília

famatuzzi@gmail.com+556199667264

Outcome results

None listed

Source: REBEC (via WHO ICTRP)